- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
HHS: Many Insurers Exaggerate the Health Conditions of Medicare Advantage Patients
HHS said that many Medicare Advantage plans wrongly inflated patient risk scores, costing the government billions. Although no insurers were specifically named, HHS researchers said it was evident that the practice of overbilling was occurring industry wide.
HHS said that many Medicare Advantage plans wrongly inflated patient risk scores, costing the government billions. Although no insurers were specifically named, HHS researchers said it was evident that the practice of overbilling was occurring industry wide.
“This is clearly impacting what taxpayers are paying for Medicare Advantage, I think, not in a good way,” said David Wennberg, MD, MS, a researcher at the Dartmouth Institute for Health Policy and Clinical Practice.
Many insurers had a high number of medical condition reports, including an unusual number of patients with diabetes complications. A Center for Public Integrity investigation, which conducted a similar analysis to HHS, also found that Medicare made an estimated $70 million in “improper” payments to Medicare Advantage plans from 2008-2013. Investigation into the overages found that many Medicare Advantage plans regularly exaggerated the conditions of their patients and how much it cost to treat them.
“Further policy changes will likely be necessary,” said HHS researchers.
However, some insurance companies are becoming more accountable for appropriate care. Texas-based Centene Superior HealthPlan, for instance, said they would take a more targeted approach to reimbursing providers for value-based diabetes care. Although many pay-for-performance reimbursement models have been established for primary care, few programs specifically target diabetes.
Centene Superior HealthPlan said it planned to collaborate with Health Care Incentives Institute in a “Bridges to Excellence” program that will give bonus payments to providers based on the quality of diabetes care they deliver. The program initially will include 2600 patients with diabetes.
“Paramount to Superior is ensuring that our members receive the highest standard of care,” said Superior HealthPlan chief medical officer David Harmon, MD, in a media release. “We hope to further encourage exemplary service from our network of doctors while also recognizing them for the excellent care they provide.”
Around the Web
HHS Report Finds Medicare Advantage Plans Exaggerate Members’ Diseases To Make More Money [Kaiser Health News]
Medicaid Plans See Need for Value-Based Diabetes Care [Healthcare Payer News]
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
